About UNION Therapeutics
UNION Therapeutics is a company based in Hellerup (Denmark) founded in 2013 by Rasmus Vendler Toft-Kehler.. UNION Therapeutics has raised $57.06 million across 12 funding rounds from investors including European Commission, European Investment Bank and European Union. The company has 26 employees as of November 30, 2024. UNION Therapeutics offers products and services including Orismilast and Pipeline Drugs. UNION Therapeutics operates in a competitive market with competitors including Spero Therapeutics, Nabriva, ASLAN Pharmaceuticals, Melinta Therapeutics and Iterum Therapeutics, among others.
- Headquarter Hellerup, Denmark
- Employees 26 as on 30 Nov, 2024
- Founders Rasmus Vendler Toft-Kehler
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Union Therapeutics A/S
-
Annual Revenue
$69.74 K (USD)-18as on Dec 31, 2022
-
Net Profit
-
EBITDA
-
Total Equity Funding
$57.06 M (USD)
in 12 rounds
-
Latest Funding Round
$6.89 M (USD), Series B
Jun 30, 2022
-
Investors
European Commission
& 5 more
-
Employee Count
26
as on Nov 30, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of UNION Therapeutics
UNION Therapeutics offers a comprehensive portfolio of products and services, including Orismilast and Pipeline Drugs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatment for psoriasis and immunological conditions in clinical trials.
Develops options for atopic dermatitis and other immune disorders.
Funding Insights of UNION Therapeutics
UNION Therapeutics has successfully raised a total of $57.06M across 12 strategic funding rounds. The most recent funding activity was a Series B round of $6.89 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 12
- Last Round Series B — $6.9M
- First Round First Round
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2022 | Amount | Series B - UNION Therapeutics | Valuation |
investors |
|
| Feb, 2021 | Amount | Series B - UNION Therapeutics | Valuation |
investors |
|
| Jun, 2020 | Amount | Series A - UNION Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in UNION Therapeutics
UNION Therapeutics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include European Commission, European Investment Bank and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Finance and advisory services for infrastructure projects are provided.
|
Founded Year | Domain | Location | |
|
Early stage VC firm investing in Denmark
|
Founded Year | Domain | Location | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by UNION Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - UNION Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Union Therapeutics Comparisons
Competitors of UNION Therapeutics
UNION Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Spero Therapeutics, Nabriva, ASLAN Pharmaceuticals, Melinta Therapeutics and Iterum Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for drug-resistant bacterial infections are developed.
|
|
| domain | founded_year | HQ Location |
Pleuromutilin antibiotics are developed for MDR infections.
|
|
| domain | founded_year | HQ Location |
Targeted small molecules are developed for oncology treatments.
|
|
| domain | founded_year | HQ Location |
Developer of bacterial ribosome-targeting drugs for MDR infections
|
|
| domain | founded_year | HQ Location |
Developer of antibiotics for MDR infections
|
|
| domain | founded_year | HQ Location |
Therapies for multi-drug resistant infections are developed using bacteriophages.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Union Therapeutics
Frequently Asked Questions about UNION Therapeutics
When was UNION Therapeutics founded?
UNION Therapeutics was founded in 2013.
Where is UNION Therapeutics located?
UNION Therapeutics is headquartered in Hellerup, Denmark.
Who is the current CEO of UNION Therapeutics?
Kim Domela Kjoller is the current CEO of UNION Therapeutics.
Is UNION Therapeutics a funded company?
UNION Therapeutics is a funded company, having raised a total of $57.06M across 12 funding rounds to date. The company's 1st funding round was a Series A of $2.24M, raised on Aug 12, 2013.
How many employees does UNION Therapeutics have?
As of Nov 30, 2024, the latest employee count at UNION Therapeutics is 26.
What is the annual revenue of UNION Therapeutics?
Annual revenue of UNION Therapeutics is $69.74K as on Dec 31, 2022.
What does UNION Therapeutics do?
UNION Therapeutics was founded in 2013 in Hellerup, Denmark, within the biotechnology sector. Small molecule drugs are developed to address antibiotic resistance in treating bacterial infections and associated conditions. The lead candidate, ATx201, serves as a topical treatment for skin infections. Additional programs include ATx202 for topical acne therapy and ATx401 for oral treatment of C. difficile infections. Operations center on advancing these therapies through research and development.
Who are the top competitors of UNION Therapeutics?
UNION Therapeutics's top competitors include Spero Therapeutics, Melinta Therapeutics and ASLAN Pharmaceuticals.
What products or services does UNION Therapeutics offer?
UNION Therapeutics offers Orismilast and Pipeline Drugs.
Who are UNION Therapeutics's investors?
UNION Therapeutics has 6 investors. Key investors include European Commission, European Investment Bank, European Union, Innovationsfonden, and ADT Foundation.
What is UNION Therapeutics's valuation?
The valuation of UNION Therapeutics is $105.68M as of Jun 2020.